Moderna (MRNA) rises on FT report about bird flu vaccines
Tweet Send to a Friend
Shares of Moderna (NASDAQ: MRNA) are up 2.8% premarket Thursday after a report from The Financial Times said US government ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


